Evaluation of buprenorphine in a postoperative pain model in rats

Comparative Medicine

Volumn 59, Issue 1, 2009, Pages 60-71

  Curtin, Leslie I ^a   Grakowsky, Julie A ^b   Suarez, Mauricio ^b   Thompson, Alexis C ^c   Dipirro, Jean M ^d   Martin, Lisa B E ^a   Kristal, Mark B ^b  

^a Sch of Med and Biomedical Sciences   (United States)

^b Department of Psychology ^*  (United States)

^c RESEARCH INSTITUTE ON ADDICTIONS   (United States)

^d BUFFALO STATE COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TOLERANCE; EXPERIMENTAL RAT; HYPERALGESIA; LOCOMOTION; MALE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; POSTOPERATIVE PAIN; RAT;

ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HYPERALGESIA; INJECTIONS, SUBCUTANEOUS; LOCOMOTION; MALE; MORPHINE; PAIN MEASUREMENT; PAIN THRESHOLD; PAIN, POSTOPERATIVE; RATS; RATS, LONG-EVANS; TIME FACTORS;

EID: 63449098140     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Abbott FV, Bonder M. 1997. Options for management of acute pain in the rat. Vet Rec 140:553-557.
2. Bailey CP, Connor M. 2005. Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5:60-68.
3. Brennan TJ. 1999. Post-operative models of nociception. ILAR J 40:129-136.
4. Brennan TJ, Vandermeulen EP, Gebhart GF. 1996. Characterization of a rat model of incisional pain. Pain 64:493-501.
5. Campora E, Merlini L, Pace M, Bruzzone M, Gottlieb A, Rosso R. 1991. The incidence of narcotic-induced emesis. J Pain Symptom Manage 6:428-430.
6. Célérier E, Rivat C, Jun Y, Laulin JP, Larcer A, Reynier P, Simon- net G. 2000. Long-lasting hyperalgesia induced by fentanyl in rats: preventative effect of ketamine. Anesthesiology 92:465-472.
7. Cowen A, Lewis JW, Macf arlane IR. 1977. Agonist and antagonist properties of buprenorphin, a new antinociceptive agent. Br J Pharmacol 60:537-545.
8. Devillers JP, Boisserie F, Laulin JP, Larcher A, Simonnet G. 1995. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats. Brain Res 700:173-181.
9. Dixon WJ. 1980. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20:441-462.
10. Flecknell PA. Laboratory animal anesthesia, 2nd ed. San Diego (CA): Academic Press; 1996.
11. Grecksch G, Bartzsch K, Widera A, Becker A, Höllt V, Koch T. 2006. Development of tolerance and sensitization to different opioid agonists in rats. Psychopharmacology (Berlin) 186:177-184.
12. Hahn EF. 1985. Testing and evaluation of opiate analgesics and antagonists. Methods Find Exp Clin Pharmacol 7:373-381.
13. Khallouk-Bousselmame R, Costentin J. 1994. Locomotor and analgesic effects of morphine and acetorphan in rats chronically treated with morphine or thiorphan. Eur Neuropsychopharmacol 4:137-143.
14. Larcher A, Laulin JP, Célérier E, Le Moal M, Simonnet G. 1998. Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience 84:583-589.
15. Martin LBE, Thompson AC, Martin T, Kristal MB. 2001. Efficacy of orally administered buprenorphine in rats. Comp Med 51:43-48.
16. Melzack R, Coderre TJ, Katz J, Vaccarino AL. 2001. Central neuroplasticity and pathological pain. Ann N Y Acad Sci 933:157-174.
17. National Institutes of Health. Public Health Service Policy on Humane Care and Use of Laboratory Animals. Bethesda (MD): Office of Laboratory Animal Welfare, National Institutes of Health; 2002.
18. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academy Press; 1996.
19. Randall LO, Sellitto JJ. 1957. A method for the measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111:409-419.
20. Richebé P, Rivat C, Laulin JP, Maurette P, Simonnet G. 2005. Ketamine improves the management of exaggerated postoperative pain observed in perioperative fentanyl-treated rats. Anesthesiology 102:421-428.
21. Schug SA, Zech D, Grond S. 1992. Adverse effects of systemic opioid analgesics. Drug Saf 7:200-213.
22. Spanagel R. 1995. Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav Brain Res 70:37-49.
23. Stewart L, Martin WJ. 2003. Evaluation of postoperative analgesia in a rat model of incisional pain. Contemp Top Lab Anim Sci 42:28-34.
24. Terenius L, Tamsen A. 1982. Endorphins and the modulation of acute pain. Acta Anaesthesiol Scand Suppl 74:21-24.
25. Thompson AC, Kristal MB, Salaj A, Acheson A, Martin LBE, Martin T. 2004. Analgesic efficacy of oral buprenorphine in rats: methodological considerations. Comp Med 54:293-300.
26. Vanderschuren LJMJ, De Vries TJ, Wardeh G, Hogenboom FACM, Schoffelmeer ANM. 2001. A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats. Eur J Neurosci 14:1533-1538.
27. White DA, Kalinichev M, Holtzman SG. 2004. Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. II. Agonist-induced antinociception and antagonist-induced suppression of fluid consumption. Psychopharmacology (Berlin) 177:68-78.
28. Whiteside GT, Harrison J, Bolet J, Mark L, Pearson M, Gottshall S, Walker K. 2004. Pharmacological characterization of a rat model of incisional pain. Br J Pharmacol 141:85-91.
29. Wilder-Smith OHG. 2000. Changes in sensory processing after surgical nociception. Curr Rev Pain 4:234-241.
30. Yim GK, Lowy MT. 1984. Opioids, feeding, and anorexias. Fed Proc 43:2893-2897.
31. Zahn PK, Brennan TJ. 1999. Primary and secondary hyperalgesia in a rat model for human postoperative pain. Anesthesiology 90:863-872.